Research Areas and Clinical Trials

These projects will increase our understanding about coronary heart disease and its treatments, including genetic factors, biological mechanisms, and new technology.

Our genetic and molecular research focuses on how biomarkers (such as DNA mutations and blood proteins) affect heart and vascular disease. We also collect DNA samples and actively follow patients and family members with genetic, or inherited forms of heart disease.

Our heart failure research focuses on improving quality of life and making therapies more precise and effective for every patient.

Our heart rhythm research focuses on improving ablation therapies, medicines, and the connection between atrial fibrillation, blood thinners, and dementia.

Our heart valve and structural heart research focuses on the development and improvement of catheter-based therapies such as transcatheter aortic and mitral valve replacement.

These projects will increase our understanding about how medications and lifestyle changes reduce the effects of cardiovascular risk factors, including high blood pressure, high cholesterol, and excess weight or obesity.

The Intermountain Spontaneous Coronary Artery Dissection (SCAD) Research Group has a special interest in this rare condition that causes heart attack in young athletes and women during or shortly after pregnancy.

Are you at risk for heart disease or diabetes? If so, you may be eligible to participate in a clinical trial that investigates the effects of intermittent fasting on your health.